Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription

Articles published in Clin Exp Immunol

Retrieve available abstracts of 7 articles:
HTML format

Single Articles

    August 2021
  1. ZHANG QX, Zhang SN, Zhang LJ, Zhang DQ, et al
    Irisin levels in the serum and cerebrospinal fluid of patients with multiple sclerosis and the expression and distribution of irisin in experimental autoimmune encephalomyelitis.
    Clin Exp Immunol. 2021 Aug 24. doi: 10.1111/cei.13656.
    PubMed     Abstract available

    March 2021
  2. HAQUE R, Kim Y, Park K, Jang H, et al
    Altered distributions in circulating follicular helper and follicular regulatory T cells accountable for imbalanced cytokine production in multiple sclerosis.
    Clin Exp Immunol. 2021 Mar 24. doi: 10.1111/cei.13596.
    PubMed     Abstract available

    September 2020
  3. JORGENSEN LO, Hyrlov KH, Elkjaer ML, Weber AB, et al
    Cladribine modifies functional properties of microglia.
    Clin Exp Immunol. 2020;201:328-340.
    PubMed     Abstract available

    August 2020
  4. YACOV N, Kafri P, Salem Y, Propheta-Meiran O, et al
    MOSPD2 is a therapeutic target for the treatment of CNS inflammation.
    Clin Exp Immunol. 2020;201:105-120.
    PubMed     Abstract available

    July 2020
  5. UZAWA A, Mori M, Masuda H, Ohtani R, et al
    Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder.
    Clin Exp Immunol. 2020 Jul 8. doi: 10.1111/cei.13487.
    PubMed     Abstract available

    June 2019
    Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases.
    Clin Exp Immunol. 2019;196:318-327.
    PubMed     Abstract available

    May 2019
  7. AQEL SI, Kraus EE, Jena N, Kumari V, et al
    Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development.
    Clin Exp Immunol. 2019;196:215-225.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.